5 withdrawn. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Withdrawn 5 |
Follow Nephritis: new trials by email Literature Review of Nephritis trials Research Report on Nephritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pentoxifylline in Lupus Nephritis Pentoxifylline, Placebos - Lupus Nephritis | Phase 4 | Withdrawn | MetroHealth Medical Center | 2020-09-01 | 2021-02-02 | |
| Acthar on Proteinuria in IgA Nephropathy Patients Acthar 80 unit injection - IgA Nephropathy, Proteinuria | Phase 4 | Withdrawn | Baylor College of Medicine | 2015-02-01 | 2017-04-05 | |
| ACTHAR GEL in Patients With Membranous (Class V) Lupus Nephritis Acthar gel - SLE Glomerulonephritis Syndrome, WHO Class V | Phase 4 | Withdrawn | Ohio State University | 2013-07-01 | 2018-05-11 | |
| Velcade for Proliferative Lupus Nephritis Velcade - Lupus Nephritis, Proteinuria | Phase 4 | Withdrawn | The Rogosin Institute | 2010-08-01 | 2012-04-24 | |
| The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria Calcitriol, Multivitamin - Systemic Lupus Erythematosus, Nephritis | Phase 4 | Withdrawn | Chinese University of Hong Kong | 2008-05-01 | 2015-08-04 |
Lupus Nephritis (4) · Proteinuria (3) · Glomerulonephritis, IGA (1) · Hematuria (1) · Lupus Erythematosus, Systemic (1) · Renal Insufficiency, Chronic (1)
Autoimmune Diseases (5) · Female Urogenital Diseases (5) · Female Urogenital Diseases and Pregnancy Complications (5) · Glomerulonephritis (5) · Immune System Diseases (5) · Kidney Diseases (5) · Male Urogenital Diseases (5) · Urogenital Diseases (5) · Urologic Diseases (5) · Connective Tissue Diseases (4) · Skin and Connective Tissue Diseases (4) · Lupus Erythematosus, Systemic (3) · Pathological Conditions, Signs and Symptoms (3) · Signs and Symptoms (3)
Bortezomib (1) · Calcitriol (1) · Geritol (1) · Pentoxifylline (1) · Proteasome Inhibitors (1)
Baylor College of Medicine (1) · Chinese University of Hong Kong (1) · MetroHealth Medical Center (1) · Ohio State University (1) · The Rogosin Institute (1)
United States (4)
Brad H Rovin, MD (1) · Cheuk-Chun Szeto, MD (1) · Choli Hartono, MD (1) · David Sheikh-Hamad, MD (1) · Stanley Ballou, MD (1)